Larger and longer studies in broader populations are needed to fully understand the safety and efficacy in people with alcohol use disorder, but these initial findings are promising. About this study: In addition to Hendershot and Klein, other authors of the study are Michael Bremmer, Michael Paladino, Georgios Kostantinis, Thomas Gilmore, Neil Sullivan, Amanda Tow and Robyn Jordan, all of University of North Carolina at Chapel Hill
Regulatory approvals for weight management indications, including expanded labels for cardiovascular risk reduction in overweight adults, have unlocked primary care prescribing and direct-to-consumer demand
We help tailor frequency based on how you feel and what you want to support long term
[6] [8] Several ongoing clinical trials are specifically examining GLP-1 receptor agonists for alcohol use disorder
This ensures results are safe, consistent, and tailored to each individuals goals